XML 41 R32.htm IDEA: XBRL DOCUMENT v3.2.0.727
Note A - Organization and Summary of Significant Accounting Policies (Details Textual)
$ / shares in Units, € in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 19, 2015
shares
Mar. 07, 2014
shares
Jul. 01, 2013
USD ($)
Jun. 01, 2013
USD ($)
Dec. 01, 2012
USD ($)
Oct. 03, 2012
USD ($)
Jul. 12, 2012
USD ($)
Mar. 13, 2012
USD ($)
Mar. 31, 2014
USD ($)
Mar. 31, 2012
USD ($)
Jan. 31, 2012
USD ($)
Jun. 30, 2011
USD ($)
Sep. 30, 2013
shares
Jun. 30, 2015
USD ($)
$ / shares
shares
Jun. 30, 2014
USD ($)
$ / shares
shares
Jun. 30, 2013
shares
Jun. 30, 2015
EUR (€)
shares
Jun. 30, 2015
USD ($)
shares
Dec. 01, 2013
USD ($)
Amendment [Member]                                      
Proceeds from License Fees Received     $ 150,000 $ 204,167 $ 204,167   $ 354,167 $ 354,167                      
Additional License Fees Upon Achievement of Certain Milestones                 $ 2,800,000                    
Additional License Fees Receivable Upon Achievement of Certain Milestones                                     $ 150,000
Prior to Amendment [Member]                                      
Additional License Fees Upon Achievement of Certain Milestones                   $ 4,300,000                  
Additional License Fees Receivable Upon Achievement of Certain Milestones                   $ 708,334                  
Installment [Member]                                      
Number of Installment Payments                 4 6                  
Fair Value, Inputs, Level 1 [Member]                                      
Fair Value, Net Asset (Liability)                                   $ 0  
Fair Value, Inputs, Level 3 [Member]                                      
Fair Value, Net Asset (Liability)                             $ 0        
Minimum [Member]                                      
Property, Plant and Equipment, Useful Life                           1 year          
Maximum [Member]                                      
Property, Plant and Equipment, Useful Life                           39 years          
Foreign Exchange Contract [Member]                                      
Derivative, Notional Amount                                 € 23.8 $ 27,100,000  
Derivative, Remaining Maturity                           1 year 60 days          
Employee Stock Option [Member]                                      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate                           0.00%          
Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member]                                      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares                           105,000          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares                           0          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares                           $ 5.51          
Restricted Stock [Member]                                      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares                             29,720   93,866 93,866  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options                                   $ 945,000  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition                           2 years          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares                           $ 5.51 $ 5.56        
2009 Omnibus Stock Incentive Plan [Member]                                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares                           0          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares                           0          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 105,000 105,000                           98,000      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 3 years                             3 years      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares                         10,000            
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Beta Alanine Raw Material Sale Customers [Member]                                      
Concentration Risk, Percentage                           26.00%          
Accounts Receivable [Member] | Customer Concentration Risk [Member] | CSI [Member]                                      
Concentration Risk, Percentage                             23.60%        
Accounts Receivable [Member] | Customer Concentration Risk [Member]                                      
Concentration Risk, Percentage                           28.50% 26.90%        
Proceeds from License Fees Received           $ 150,000         $ 300,000 $ 300,000              
Impairment of Long-Lived Assets to be Disposed of                           $ 417,000 $ 0        
Liability for Uncertain Tax Positions, Current                             0     0  
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount                           $ 0 $ 193,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares                           0 0        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares                           0 0        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value                           $ 0 $ 121,000        
Foreign Currency Contract, Asset, Fair Value Disclosure                                   $ 474,000  
Foreign Currency Contracts, Liability, Fair Value Disclosure                             24,000        
Royalty and Licensing Revenue                           9,100,000 5,400,000        
Royalty Expense                           806,000 722,000        
Research and Development Expense                           1,100,000 1,000,000        
Advertising Expense                           $ 69,000 $ 131,000        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares                           151,000 268,000        
Concentration of Risk Number of Major Customers                           2